fgfr3: a new possible target for treating triple-negative breast cancer
Published 4 years ago • 170 plays • Length 1:51Download video MP4
Download video MP3
Similar videos
-
26:31
targeting advanced triple-negative breast cancer | dana-farber cancer institute
-
1:10
comparing 3 types of targeted therapies for triple-negative breast cancer
-
2:10
testing and targeted therapy in triple negative breast cancer: 2023 west oncology
-
2:30
highlighting a subset of tnbc for targeted therapy
-
0:53
keynote-522 demonstrates potential for immunotherapy in triple-negative breast cancer
-
4:23
a new drug could become one of the first targeted treatments for triple-negative breast cancer
-
5:55
study findings: testosterone and triple negative breast cancer - mayo clinic
-
33:30
neelima denduluri, md -- treatment of triple negative breast cancer
-
1:13
opportunities for novel targets or therapies in tnbc
-
33:41
clinical trials for metastatic breast cancer: what you should know | dana-farber cancer institute
-
3:46
case 4: parp inhibitors for treating brca triple-negative breast cancer
-
1:14
the importance of a biomarker-directed approach in triple-negative breast cancer
-
1:32
possible new therapy found for chemo-resistant breast cancer
-
46:33
new ways immunotherapy targets breast cancer, with silvia formenti
-
57:15
let’s talk about it: tnbc - the latest genetic testing guidelines
-
4:52
treatment strategies for triple-negative breast cancer
-
45:09
breast cancer: the latest target for immunotherapy, with leisha emens
-
16:43
2021 west oncology | breast cancer | new advances for metastatic tnbc
-
4:48
ar triple negative breast cancer clinical trial